HDDAH-1-IN-2
HDDAH-1-IN-2 is a selective, orally active human dimethylarginine dimethylaminohydrolase-1 (hDDAH-1) inhibitor. hDDAH-1-IN-2 reveals an excellent profile regarding cell toxicity/viability[1].
Product Specifications
CAS Number
2408834-77-3
UNSPSC
12352211
Target
Drug Intermediate
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Neurological Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hddah-1-in-2.html
Solubility
10 mM in DMSO
Smiles
NCCCCNC(NCCOC)=NO
Molecular Formula
C8H20N4O2
Molecular Weight
204.27
References & Citations
[1]Lunk I, et al. Discovery of N- (4-Aminobutyl) -N'- (2-methoxyethyl) guanidine as the First Selective, Nonamino Acid, Catalytic Site Inhibitor of Human Dimethylarginine Dimethylaminohydrolase-1 (hDDAH-1) .J Med Chem. 2020 Jan 9;63 (1) :425-432.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SP-64011-5 5 mg
Tax9, HTLV - 1 (11 - 19) (AA: Leu-Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val) (MW: 1070.31)
Sign In for Pricing
View Details 